Benserazide D3
| Product Name | Benserazide D3 |
|---|---|
| Alternate Names | Benserazide Stable Isotopes, Stable Isotopes of Benserazide |
| CAT No. | CS-CX-00158 |
| CAS No. | 322-35-0 (Unlabeled) |
| Category | Stable Isotopes |
| Stock | Enquire |
| Mol. Wt. | Not Available |
| Mol. For. | Not Available |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Benserazide |
| Smileys | OC1=C(C=CC(O)=C1O)CNNC(C(N)([2H])C([2H])([2H])O)=O |
| Canonical Smiles | C1=CC(=C(C(=C1CNNC(=O)C(CO)N)O)O)O |
| InchIKey | BNQDCRGUHNALGH-UHFFFAOYSA-N |
| Inchl | InChI=1S/C10H15N3O5/c11-6(4-14)10(18)13-12-3-5-1-2-7(15)9(17)8(5)16/h1-2,6,12,14-17H,3-4,11H2,(H,13,18) |
| IUPAC | 2-amino-3-hydroxy-N'-[(2,3,4-trihydroxyphenyl)methyl]propanehydrazide |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Benserazide D3 is a deuterated form of benserazide, a medication used in combination with levodopa to treat Parkinson's disease. It works by inhibiting the enzyme aromatic L-amino acid decarboxylase (AADC) in the brain, which converts levodopa to dopamine. By inhibiting AADC, benserazide D3 allows more levodopa to reach the brain, where it can be converted to dopamine to alleviate Parkinson's symptoms.
Chemically, benserazide D3 is a white or off-white powder with a molecular formula of C10H11D3N2O2 and a molecular weight of 191.26 g/mol. It is a deuterated form of benserazide, meaning that some of the hydrogen atoms in the molecule have been replaced with deuterium atoms.
Benserazide D3 is typically administered orally in the form of capsules or tablets. The recommended dosage varies depending on the patient's age, weight, and severity of symptoms, but typically ranges from 25-100 mg per day. Like all medications, benserazide D3 may cause side effects, including nausea, vomiting, dizziness, and dry mouth.
Overall, benserazide D3 is an important medication in the treatment of Parkinson's disease. Its ability to inhibit AADC allows for more levodopa to reach the brain, which can improve symptoms and quality of life for patients.
Get an Instant Quote
Related Compounds
Benserazide D3 Hydrochloride |